Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TBXA2R | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ADRM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | DDX28 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | DCANP1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ZDHHC11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | PPCDC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | TIRAP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | IRGM | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | RP11-574F21.3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | PRKAR2A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |